Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Elizabeth Baron

Physician Assistant Stony Brook, NY Physician Assistant

NPI 1922293141 CMS profile 11133924

101 Nicolls Rd Hscl4060, Stony Brook, NY 11794

Open in the dashboard

General payments

$4,053

109 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elizabeth Baron of Stony Brook, NY is reported in the CMS Open Payments database as having received $4,053 across 109 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,737 42
2024 General $767 19
2023 General $444 14
2022 General $572 14
2021 General $533 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elizabeth Baron
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Elizabeth Baron were reported at $1,737. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Elizabeth Baron Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $533 $132 $37–$438 $132
2022 $572 $155 $48–$522 $149
2023 $444 $167 $52–$557 $160
2024 $767 $178 $55–$600 $164
2025 $1,737 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $1,887 40 payments
  2. Abbott Laboratories $645 13 payments
  3. Relievant Medsystems, Inc. $451 8 payments
  4. Collegium Pharmaceutical, Inc. $413 21 payments
  5. Scilex Pharmaceuticals Inc. $186 9 payments
  6. Ferring Pharmaceuticals Inc. $88 3 payments
  7. Spinal Simplicity, LLC $82 3 payments
  8. AbbVie, Inc. $78 3 payments
  9. Painteq LLC $54 1 payment
  10. Arbor Pharmaceuticals, Inc. $45 2 payments
  11. Other $123 6 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,053 109 payments
Products named General payments · program years 2021–2025
  1. Intracept Contains (1)Intracept RF Probe (2)Intracept Access Instruments_NMOD $929 25 payments
  2. Intracept Pain $458 8 payments
  3. General - Pain Management $350 3 payments
  4. XTAMPZA $333 17 payments
  5. Proclaim IPG $264 6 payments
  6. Intracept Pain $245 5 payments
  7. Intracept Pain $245 5 payments
  8. Intracept Pain $245 5 payments
  9. ZTLido $186 9 payments
  10. Intracept Pain $182 2 payments
  11. Other $1,060 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

812

Median for Physician Assistant: 241

Drug cost

$42,156

Median for Physician Assistant: $4,110

Branded share of claims

27.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycontin Oxycodone Hcl Brand 36 $15,097
Xtampza Er Oxycodone Myristate Brand 25 $15,076
Pregabalin Generic 65 $2,266
Lidocaine Generic 14 $2,070
Gabapentin Generic 167 $1,675
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 100 $1,665
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 62 $1,238
Tramadol Hcl Generic 80 $595
Oxycodone Hcl Generic 64 $571
Etodolac Generic 21 $510

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ZTLido
  • Scilex Pharmaceuticals Inc. $86
$86 — —
BOTOX
  • AbbVie, Inc. $57
$57 — —
XTAMPZA
  • Collegium Pharmaceutical, Inc. $23
$23 25 —
ROXYBOND
  • PROTEGA PHARMACEUTIALS LLC $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

109 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record